Alexion Pharmaceuticals logo

Candidate-reported interview insights

Alexion Pharmaceuticals Director interviews, decoded.

Explore commonly reported questions, interview rounds, difficulty, duration, and candidate experiences for the Director role at Alexion Pharmaceuticals.

3.8 rating Biotech & Pharmaceuticals

Interview overview

Difficulty

Average

Average rounds

3.6

Average duration

~44 days

Difficulty and candidate experience

Interview difficulty

easy0%
average70%
difficult30%

Candidate experience

positive50%
negative40%
neutral10%

Candidate-reported interview process

First, I had an HR screening. Then, I had interviews with my potential manager, their manager, and some cross-functional teammates. After that, there was an HR debrief and offer discussions, which took about 2-3 weeks. I accepted the offer and completed background check and verification before starting.

The entire interview process was friendly, open, and engaging. Communication was clear, feedback was readily provided, and the pace was fast. The interviewers were consistently courteous and respectful, and they were happy to assist with any questions or aspects of the process.

I had 3 interviews. The first was with the hiring manager for 60 minutes. The second was with someone more senior for 70 minutes. The third interview was 90 minutes and I met with 3 people from the team.

Common Alexion Pharmaceuticals Director interview questions

A focused selection of the most detailed candidate-submitted questions.

  1. 1

    What is your experience with platform knowledge?

  2. 2

    Describe your experience with processes.

  3. 3

    Tell me about your previous experience.

  4. 4

    Why are you interested in this role?

Interview question formats

Behavioral50%
Technical35%
Presentation10%
Other5%

Ready to prepare for Alexion Pharmaceuticals?

Practice technical, system design, and behavioral questions with Zitlee.

Interview information is based on candidate reports and may not represent the current official hiring process of Alexion Pharmaceuticals.